sar
sever
acut
respiratori
syndrom
new
clinic
diseas
infecti
etiolog
recent
report
literatur
thought
first
origin
guangdong
provinc
china
ill
spread
rapidli
numer
part
world
includ
asia
north
america
europ
world
health
organ
identifi
suspect
probabl
sar
case
basi
clinic
epidemiolog
case
definit
suspect
case
includ
fever
cough
either
exposur
suspect
probabl
case
sar
day
prior
ill
onset
histori
travel
area
affect
sar
resid
affect
area
probabl
case
includ
chest
radiograph
infiltr
incub
period
rang
day
ill
typic
begin
fever
headach
myalgia
may
progress
lower
respiratori
tract
symptom
case
requir
mechan
ventil
agent
sar
specul
novel
coronaviru
like
transmit
via
droplet
april
sar
case
death
report
countri
http
wwwwhoint
within
canada
sar
case
probabl
suspect
provinc
death
vast
major
case
occur
toronto
area
http
wwwhcgcscca
epidemiolog
investig
link
canadian
outbreak
index
case
travel
return
hong
kong
due
larg
number
sar
case
infect
sever
health
care
worker
number
infect
control
measur
taken
ontario
hospit
includ
strict
handwash
high
filtrat
mask
gown
glove
patient
contact
visitor
polici
cancel
elect
surgeri
limit
number
activ
hospit
employe
infect
control
precaut
deal
sar
patient
avail
http
wwwcdcgovncidodsar
descript
sar
occur
organ
transplant
recipi
date
report
link
advers
event
sar
comorbid
condit
transplant
report
liver
transplant
patient
die
sar
also
set
sar
outbreak
region
develop
guidelin
screen
potenti
organ
donor
order
avoid
risk
transmiss
sar
organ
donat
patient
data
obtain
chart
review
inform
contact
provid
toronto
public
health
depart
perform
rna
extract
clinic
sampl
use
trizol
reagent
life
technolog
per
manufactur
recommend
revers
transcript
perform
describ
use
primer
follow
pcr
use
primer
target
highli
conserv
region
coronaviru
pol
code
region
name
pcr
set
describ
perform
robocycl
stratagen
cycl
consist
denatur
anneal
min
elong
min
bal
time
admiss
neg
routin
bacteri
fungal
mycobacteri
stain
cultur
direct
fluoresc
antibodi
stain
bal
fluid
neg
influenza
parainfluenza
respiratori
syncyti
viru
adenoviru
cultur
neg
routin
respiratori
virus
cytomegaloviru
legionella
special
stain
legionella
pneumocysti
neg
pcr
mycoplasma
chlamydia
cmv
antigenemia
urin
legionella
antigen
neg
perform
bal
fluid
posit
obtain
amplicon
expect
size
bp
sequenc
sequenc
ident
found
anoth
patient
sar
report
previous
sequenc
intern
primer
homolog
expect
segment
pol
code
region
sar
coronaviru
complet
sequenc
canadian
isol
bcca
genom
scienc
center
british
columbia
genbank
access
number
also
perform
coronavirus
plasma
sampl
peripher
blood
mononuclear
cell
purifi
buffi
coat
obtain
first
fifth
day
hospit
coronaviru
detect
sampl
patient
isol
reach
facil
cours
ill
sever
person
expos
includ
wife
two
children
famili
physician
fp
fp
offic
staff
sever
patient
wait
room
hospit
due
larg
outbreak
possibl
determin
expos
direct
result
patient
sever
sar
exposur
occur
time
howev
hundr
individu
hospit
place
isol
patient
two
visitor
emerg
visit
hospit
exposur
also
occur
individu
involv
transfer
patient
hospit
b
staff
hospit
b
primarili
involv
patient
icu
care
subsequ
ill
compat
suspect
probabl
sar
occur
person
patient
wife
famili
physician
two
visitor
hospit
six
staff
hospit
b
result
one
death
due
sar
like
underestim
unabl
determin
mani
hospit
expos
specif
due
patient
due
outbreak
sar
greater
toronto
area
transplant
program
citi
temporarili
close
prior
transplant
program
concern
aros
unrecogn
sar
potenti
cadaver
organ
donor
larg
unknown
potenti
spread
multipl
recipi
donor
may
risk
incub
sar
activ
sar
due
exposur
health
care
facil
specif
epidemiolog
exposur
within
commun
therefor
donor
sar
screen
tool
develop
shown
figur
screen
tool
base
inform
regard
potenti
hospit
exposur
clinic
symptom
contact
histori
section
categori
donor
institut
list
hospit
categor
base
canada
ministri
health
guidelin
rang
categori
sar
case
institut
categori
sar
exposur
spread
expos
person
other
figur
inform
readili
avail
infect
control
practition
given
institut
section
b
base
determin
clinic
radiolog
evid
sar
present
section
c
evalu
contact
exposur
either
someon
sar
suspect
probabl
due
travel
area
high
risk
sar
exposur
base
current
government
travel
advisori
avail
http
wwwcdcgov
unit
state
inform
donor
classifi
high
risk
intermedi
indetermin
risk
low
risk
base
categori
shown
bottom
figur
sinc
implement
screen
tool
practic
accept
donor
donor
gener
exclud
donor
done
discuss
transplant
team
recipi
screen
tool
modifi
live
relat
donor
label
section
categori
donor
visit
hospit
within
previou
day
also
implement
modifi
version
screen
tool
potenti
recipi
ensur
patient
incub
sar
inadvert
transplant
transplant
recipi
expos
sever
emerg
new
ill
west
nile
viru
chaga
diseas
sar
describ
first
report
case
sar
solid
organ
transplant
recipi
sever
factor
support
diagnosi
sar
patient
first
patient
symptom
compat
describ
literatur
sar
current
guidelin
probabl
sar
common
present
symptom
report
literatur
fever
case
chill
headach
myalgia
patient
may
develop
cough
short
breath
pulmonari
infiltr
addit
laboratori
abnorm
includ
lymphopenia
thrombocytopenia
mild
elev
aminotransferas
level
describ
mani
sar
patient
seen
patient
epidemiolog
evid
consist
diagnosi
sar
subsequ
spread
infect
numer
contact
includ
healthcar
worker
subsequ
develop
ill
fit
case
definit
suspect
probabl
sar
patient
die
despit
therapi
antibiot
ribavirin
prompt
reduct
immunosuppress
similar
therapi
antibiot
coverag
atyp
pneumonia
ribavirin
antivir
effect
commonli
use
treatment
sar
recent
steroid
therapi
conjunct
ribavirin
propos
howev
efficaci
treatment
larg
unknown
time
write
publish
report
data
therapi
recent
novel
coronaviru
implic
etiolog
pathogenesi
sar
implic
coronaviru
sequenc
full
sequenc
avail
genbank
access
number
also
abl
amplifi
segment
polymeras
gene
coronaviru
bal
fluid
patient
sequenc
complet
homolog
sequenc
sar
coronaviru
find
strongli
support
diagnosi
sar
consist
viral
investig
group
patient
probabl
sar
point
new
coronaviru
like
etiolog
sar
coronavir
rna
detect
nasopharyng
sampl
sar
patient
hong
kong
outbreak
addit
patient
acut
convalesc
sera
avail
show
greater
rise
antibodi
titer
viru
although
detail
discuss
laboratori
test
sar
coronaviru
beyond
scope
studi
diagnost
evalu
sar
rapidli
evolv
field
sar
viru
specif
serolog
acut
convalesc
titer
diagnost
util
assess
acut
ill
may
limit
due
delay
seroconvers
rapid
method
may
prove
use
diagnosi
acut
ill
howev
optim
method
sensit
clinic
specimen
known
http
wwwcdcgov
human
metapneumoviru
singl
agent
conjunct
coronaviru
also
isol
patient
sar
canadian
outbreak
although
recent
report
evid
viru
agent
sar
lack
number
implic
emerg
sar
transplant
first
patient
immunosuppress
may
like
develop
symptomat
sar
expos
also
although
difficult
determin
singl
case
report
like
sever
diseas
higher
mortal
rate
may
seen
transplant
patient
overal
mortal
sar
report
multivari
analys
outbreak
hong
kong
determin
advanc
age
predict
advers
outcom
found
comorbid
condit
predict
death
icu
admiss
patient
elderli
also
diabet
may
contribut
poor
outcom
howev
data
respiratori
virus
suggest
greater
morbid
mortal
transplant
recipi
addit
possibl
transplant
recipi
sar
may
shed
larg
amount
viru
prolong
period
time
result
spread
greater
number
contact
ie
recent
identifi
certain
sar
outbreak
hong
kong
singapor
http
wwwwhoint
may
part
respons
rapid
spread
sar
across
world
may
lead
stricter
infect
control
precaut
group
patient
due
outbreak
sar
commun
transplant
program
greater
toronto
area
hospit
sick
children
st
michael
hospit
univers
health
network
temporarili
close
due
concern
regard
recipi
safeti
hospit
ensur
donor
safe
use
like
use
organ
donor
activ
incub
sar
could
potenti
infect
organ
recipi
highest
likelihood
may
lung
transplant
set
sinc
appear
primari
site
diseas
find
evid
viremia
patient
suggest
viremia
may
short
live
howev
recent
studi
found
detect
coronaviru
serum
sputum
stool
varieti
tissu
includ
lung
kidney
bone
marrow
patient
sar
therefor
like
transmiss
sar
nonpulmonari
organ
transplant
also
possibl
addit
find
viru
serum
impli
potenti
viral
transmiss
via
blood
product
lack
rapid
diagnost
techniqu
sar
clinic
screen
tool
may
use
donor
potenti
diseas
transmiss
even
use
rapid
clinic
test
donor
incub
sar
earli
sar
may
miss
therefor
develop
donor
screen
tool
sar
risk
stratif
although
recent
initi
believ
allow
clinician
patient
formul
structur
understand
potenti
risk
sar
donor
base
screen
tool
donor
classifi
high
intermedi
low
risk
donor
gener
exclud
donor
use
donor
discuss
basi
reach
decis
use
organ
slightli
modifi
screen
tool
use
potenti
recipi
avoid
inadvert
transplant
someon
may
incub
sar
experi
valid
gain
screen
tool
modif
undoubtedli
made
similarli
inform
gain
etiolog
epidemiolog
sar
diagnost
test
develop
screen
sar
continu
evolv
sar
continu
spread
around
world
like
transplant
program
face
similar
issu
grate
acknowledg
cameron
guest
ontario
trillium
gift
life
network
assist
develop
implement
donor
sar
screen
tool
grate
acknowledg
dr
toni
mazzulli
laboratori
support
assist
toronto
public
health
depart
deepali
kumar
support
research
fellowship
canadian
institut
health
research
raymond
tellier
support
grant
canadian
institut
health
research
author
potenti
conflict
interest
